Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Nicoletta Ferrari(Alleanza Contro il Cancro), Paola Barboro(Ospedale Policlinico San Martino)
Cited by 34
Related Papers
AKT/NF‐κB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies
|Cancer|2007|76
Xanthohumol Impairs Human Prostate Cancer Cell Growth and Invasion and Diminishes the Incidence and Progression of Advanced Tumors in TRAMP Mice
|Molecular Medicine|2012|66
The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3β pathway and β-catenin stability
|Molecular Cancer|2010|48
Prostate cancer: Prognostic significance of the association of heterogeneous nuclear ribonucleoprotein K and androgen receptor expression
|International Journal of Oncology|2014|30
A hnRNP K–AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer
|International Journal of Molecular Sciences|2018|25